Tembeka Sineke [Researcher - Epidemiology]

T: (0)10 001 2942  
Tembeka Sineke

Tembeka Sineke joined HE2RO in January 2015 as a Research Fellow and has since been promoted to a Research Associate and then a Researcher in January 2018.  She has completed an MPH in Epidemiology and Biostatistics, from the University of Cape Town, and holds an undergraduate degree in Medical Bioscience, as well as a Honours in Infectious Diseases and Immunology. She previously worked at the Centre for Infectious Diseases and Epidemiology Research (CIDER), at the School of Public Health and Family Medicine at UCT and also worked with Médecins Sans Frontières, or Doctors Without Borders (MSF). She is currently involved in research related to characteristics of HIV-positive patients who experienced an elevated viral load >1000 copies/ml on second-line antiretroviral therapy, as well as research pertaining to the quality of life and adverse events among a cross-section of drug-resistant TB at the Helen Joseph Hospital, Johannesburg, South Africa


  • Rates and predictors of ART refusal under the universal-test-and-treat (UTT) policy in South Africa

    Although almost four of seven million persons living with HIV on antiretroviral therapy (ART), an additional 2.5 million individuals must be initiated on ART to reach the target of initiating 90% of diagnosed HIV positive patients on ART by 2020. However, an estimated 20% of South African patients eligible under CD4<200 eligibility threshold were likely to refuse ART. With the removal of CD4 eligibility thresholds in 2016, it is unclear whether the demand for ART has improved and 
  • Building the Capacity of Lay Health Counsellors to Improve ART Uptake among High CD4 Patients under the “Treat All’ Policy in South Africa

    In September 2016, South Africa began implementing test-and-treat, in which everyone who tests HIV positive is offered antiretroviral therapy (ART), in hopes of attaining the UNAIDS 90-90-90 targets. However the success of the test-and-treat approach depends on early HIV testing and lifelong HIV treatment. In South Africa, lay HIV counselors are the first to introduce ART to newly diagnosed patients. However, most are under-trained with little professional supervision and emotional support and